Fusion Pharmaceuticals Inc (FUSN) Insider Trading
- $12,486,335.71
- $573,801.72
- Aug. 11, 2022
- John Valliant
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 11, 2022 | Director | 44,400 | $2.03 | Buy | $90,132.00 | |
| April 27, 2022 | CEO | 4,511 | $6.03 | Sell | $27,201.33 | |
| April 25, 2022 | CEO | 2,036 | $6.03 | Sell | $12,277.08 | |
| April 20, 2022 | CEO | 367 | $6.02 | Sell | $2,209.34 | |
| April 13, 2022 | CEO | 11,994 | $6.41 | Sell | $76,881.54 | |
| April 11, 2022 | CEO | 2,600 | $7.37 | Sell | $19,162.00 | |
| April 8, 2022 | CEO | 826 | $7.52 | Sell | $6,211.52 | |
| April 6, 2022 | CEO | 100 | $7.58 | Sell | $758.00 | |
| March 30, 2022 | CEO | 300 | $7.52 | Sell | $2,256.00 | |
| March 28, 2022 | CEO | 9,600 | $7.55 | Sell | $72,480.00 | |
| March 25, 2022 | CEO | 500 | $7.42 | Sell | $3,710.00 | |
| March 23, 2022 | CEO | 100 | $7.50 | Sell | $750.00 | |
| March 21, 2022 | CEO | 1,500 | $7.47 | Sell | $11,205.00 | |
| March 17, 2022 | CEO | 900 | $7.51 | Sell | $6,759.00 | |
| March 7, 2022 | CEO | 3,100 | $6.99 | Sell | $21,669.00 | |
| March 4, 2022 | CEO | 8,400 | $7.32 | Sell | $61,488.00 | |
| Feb. 28, 2022 | CEO | 3,100 | $7.40 | Sell | $22,940.00 | |
| Feb. 24, 2022 | CEO | 2,500 | $7.41 | Sell | $18,525.00 | |
| Feb. 22, 2022 | CEO | 4,100 | $7.85 | Sell | $32,185.00 | |
| Feb. 17, 2022 | CEO | 1,700 | $7.98 | Sell | $13,566.00 | |
| Feb. 15, 2022 | CEO | 12,600 | $8.33 | Sell | $104,958.00 | |
| Aug. 23, 2021 | Director | 2,829 | $7.99 | Buy | $22,603.71 | |
| Aug. 16, 2021 | Director | 6,000 | $8.10 | Buy | $48,600.00 | |
| Dec. 23, 2020 | Major Shareholder | 4,569 | $12.39 | Sell | $56,609.91 | |
| June 30, 2020 | Major Shareholder | 725,000 | $17.00 | Buy | $12,325,000.00 |
Insiders are both buying and selling Fusion Pharmaceuticals Inc stock.
The insider traders at Fusion Pharmaceuticals Inc are: John Valliant, Steven Gannon, Adams Street Partners Llc, and Johnson & Johnson
The most active insider trader at Fusion Pharmaceuticals Inc is John Valliant with 20 trades.
John Valliant has sold the most Fusion Pharmaceuticals Inc stock with a total value of $544,393.14.
Johnson & Johnson has bought the most Fusion Pharmaceuticals Inc stock with a total value of $24,650,000.00.
The most recent insider trade for Fusion Pharmaceuticals Inc was on Aug. 11, 2022.
The single biggest insider buy for Fusion Pharmaceuticals Inc was from Johnson & Johnson with a total value of $12,325,000.00 on June 30, 2020.
The single biggest insider sell for Fusion Pharmaceuticals Inc was from John Valliant with a total value of $104,958.00 on Feb. 15, 2022.